SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009109
Filing Date
2018-11-09
Accepted
2018-11-09 07:47:29
Documents
54
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q btai-20180930x10q.htm 10-Q 1544364
2 EX-10.1 btai-20180930ex10136c792.htm EX-10.1 608699
3 EX-31.1 btai-20180930ex311b4f08c.htm EX-31.1 11636
4 EX-31.2 btai-20180930ex31281072c.htm EX-31.2 12457
5 EX-32.1 btai-20180930ex3217cfc66.htm EX-32.1 7125
6 EX-32.2 btai-20180930ex322e39dc3.htm EX-32.2 7154
  Complete submission text file 0001558370-18-009109.txt   5138131

Data Files

Seq Description Document Type Size
7 EX-101.INS btai-20180930.xml EX-101.INS 778507
8 EX-101.SCH btai-20180930.xsd EX-101.SCH 34820
9 EX-101.CAL btai-20180930_cal.xml EX-101.CAL 31149
10 EX-101.DEF btai-20180930_def.xml EX-101.DEF 108884
11 EX-101.LAB btai-20180930_lab.xml EX-101.LAB 285889
12 EX-101.PRE btai-20180930_pre.xml EX-101.PRE 218129
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38410 | Film No.: 181171393
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences